Eli Lilly Reports Positive Results From Study of Weight Loss Drug

Core Insights - Eli Lilly's experimental weight-loss drug retatrutide has shown significant efficacy in reducing weight and alleviating knee pain in a phase three trial involving patients suffering from obesity and knee osteoarthritis [1] Group 1 - The phase three trial demonstrated that retatrutide resulted in substantial weight loss among participants [1] - Patients reported a reduction in knee pain, indicating potential benefits for those with knee osteoarthritis [1]